LTX-109
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for LTX-109, covering 2011-06-08 to 2021-09-20. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate a Single Dose of LTX-109 in Subjects With COVID-19 (Coronavirus Disease 2019) Infection. [Phase 2]